what are the side effects of a glp 1 Q&A: Long-term success GLP-1 therapies hinges on more than just prescription What is GLP-1? Benefits, Uses

Eli Lilly is planning to submit orforglipron (Foundayo) for the treatment of T2DM in the second quarter of 2026 under the CNPV pilot program, making it possible for the drug to receive FDA approval in late 2026

Although more commonly associated with gastroparesis, evidence suggests that GLP-1 RAs can also delay small bowel transit, leading to small bowel obstruction in susceptible individuals

Laboratory analysis Glucose was collected into fluoride oxalate tubes and measured using an Architect ci8200 analyzer (Abbott Diagnostics, Maidenhead, UK), with an assay detection limit of 0.3 mmol/L and an intra-assay coefficient of variation (CV) of 1 %

Circulation 145 , e722e759 (2022)